Annual Revenue
$6.88 M
+$4.53 M+192.02%
31 December 2023
Summary:
Celldex Therapeutics annual revenue is currently $6.88 million, with the most recent change of +$4.53 million (+192.02%) on 31 December 2023. During the last 3 years, it has fallen by -$535.00 thousand (-7.21%). CLDX annual revenue is now -85.29% below its all-time high of $46.79 million, reached on 31 December 2010.CLDX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$3.19 M
+$693.00 K+27.74%
01 September 2024
Summary:
Celldex Therapeutics quarterly revenue is currently $3.19 million, with the most recent change of +$693.00 thousand (+27.74%) on 01 September 2024. Over the past year, it has increased by +$1.67 million (+110.35%). CLDX quarterly revenue is now -91.54% below its all-time high of $37.72 million, reached on 31 December 2010.CLDX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$9.98 M
+$1.67 M+20.16%
01 September 2024
Summary:
Celldex Therapeutics TTM revenue is currently $9.98 million, with the most recent change of +$1.67 million (+20.16%) on 01 September 2024. Over the past year, it has increased by +$5.61 million (+128.55%). CLDX TTM revenue is now -78.68% below its all-time high of $46.79 million, reached on 31 December 2010.CLDX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +192.0% | +110.3% | +128.6% |
| 3 y3 years | -7.2% | +1985.6% | +23.1% |
| 5 y5 years | -27.8% | +484.4% | +124.2% |
CLDX Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -7.2% | +192.0% | -22.8% | +1985.6% | at high | +1110.7% |
| 5 y | 5 years | -27.8% | +192.0% | -22.8% | +1985.6% | at high | +1110.7% |
| alltime | all time | -85.3% | +6783.0% | -91.5% | +187.4% | -78.7% | +474.6% |
Celldex Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.19 M(+27.7%) | $9.98 M(+20.2%) |
| June 2024 | - | $2.50 M(+1501.3%) | $8.30 M(+36.7%) |
| Mar 2024 | - | $156.00 K(-96.2%) | $6.07 M(-11.8%) |
| Dec 2023 | $6.88 M(+192.0%) | $4.13 M(+172.3%) | $6.88 M(+57.7%) |
| Sept 2023 | - | $1.52 M(+466.0%) | $4.37 M(+34.1%) |
| June 2023 | - | $268.00 K(-72.3%) | $3.25 M(+3.3%) |
| Mar 2023 | - | $967.00 K(-40.0%) | $3.15 M(+33.6%) |
| Dec 2022 | $2.36 M(-49.3%) | $1.61 M(+296.3%) | $2.36 M(+118.6%) |
| Sept 2022 | - | $407.00 K(+149.7%) | $1.08 M(+30.8%) |
| June 2022 | - | $163.00 K(-6.3%) | $824.00 K(-80.1%) |
| Mar 2022 | - | $174.00 K(-47.9%) | $4.14 M(-11.0%) |
| Dec 2021 | $4.65 M(-37.3%) | $334.00 K(+118.3%) | $4.65 M(-42.6%) |
| Sept 2021 | - | $153.00 K(-95.6%) | $8.10 M(-6.0%) |
| June 2021 | - | $3.48 M(+408.0%) | $8.62 M(+60.4%) |
| Mar 2021 | - | $685.00 K(-81.9%) | $5.37 M(-27.5%) |
| Dec 2020 | $7.42 M(+107.6%) | $3.79 M(+466.6%) | $7.42 M(+64.1%) |
| Sept 2020 | - | $668.00 K(+183.1%) | $4.52 M(+2.8%) |
| June 2020 | - | $236.00 K(-91.3%) | $4.40 M(-9.8%) |
| Mar 2020 | - | $2.73 M(+207.6%) | $4.88 M(+36.5%) |
| Dec 2019 | $3.57 M(-62.5%) | $887.00 K(+62.5%) | $3.57 M(-19.7%) |
| Sept 2019 | - | $546.00 K(-23.6%) | $4.45 M(-8.2%) |
| June 2019 | - | $715.00 K(-49.8%) | $4.84 M(-29.7%) |
| Mar 2019 | - | $1.43 M(-19.2%) | $6.89 M(-27.7%) |
| Dec 2018 | $9.54 M(-25.2%) | $1.76 M(+87.5%) | $9.54 M(-15.1%) |
| Sept 2018 | - | $941.00 K(-65.9%) | $11.23 M(-21.0%) |
| June 2018 | - | $2.76 M(-32.1%) | $14.21 M(-7.0%) |
| Mar 2018 | - | $4.07 M(+17.7%) | $15.28 M(+19.9%) |
| Dec 2017 | $12.74 M(+87.8%) | $3.46 M(-11.9%) | $12.74 M(+14.2%) |
| Sept 2017 | - | $3.92 M(+2.5%) | $11.16 M(+18.0%) |
| June 2017 | - | $3.83 M(+149.6%) | $9.46 M(+34.8%) |
| Mar 2017 | - | $1.53 M(-18.1%) | $7.02 M(+3.4%) |
| Dec 2016 | $6.79 M(+23.8%) | $1.87 M(-15.6%) | $6.79 M(+1.2%) |
| Sept 2016 | - | $2.22 M(+59.8%) | $6.70 M(+21.7%) |
| June 2016 | - | $1.39 M(+6.6%) | $5.51 M(-12.5%) |
| Mar 2016 | - | $1.30 M(-27.2%) | $6.30 M(+14.9%) |
| Dec 2015 | $5.48 M(+52.8%) | $1.79 M(+74.6%) | $5.48 M(+6.1%) |
| Sept 2015 | - | $1.03 M(-52.9%) | $5.17 M(-1.4%) |
| June 2015 | - | $2.18 M(+348.1%) | $5.24 M(+43.4%) |
| Mar 2015 | - | $486.00 K(-67.1%) | $3.66 M(+2.0%) |
| Dec 2014 | $3.59 M(-12.8%) | $1.48 M(+34.2%) | $3.59 M(+31.4%) |
| Sept 2014 | - | $1.10 M(+86.0%) | $2.73 M(+4.6%) |
| June 2014 | - | $592.00 K(+42.3%) | $2.61 M(+23.4%) |
| Mar 2014 | - | $416.00 K(-32.9%) | $2.11 M(-48.6%) |
| Dec 2013 | $4.11 M(-63.3%) | $620.00 K(-36.7%) | $4.11 M(-42.4%) |
| Sept 2013 | - | $980.00 K(+910.3%) | $7.14 M(-23.0%) |
| June 2013 | - | $97.00 K(-96.0%) | $9.27 M(-17.1%) |
| Mar 2013 | - | $2.41 M(-33.8%) | $11.18 M(-0.2%) |
| Dec 2012 | $11.20 M(+20.9%) | $3.65 M(+17.2%) | $11.20 M(+12.1%) |
| Sept 2012 | - | $3.11 M(+55.0%) | $9.99 M(+8.1%) |
| June 2012 | - | $2.01 M(-17.4%) | $9.24 M(+0.6%) |
| Mar 2012 | - | $2.43 M(-0.0%) | $9.18 M(-0.9%) |
| Dec 2011 | $9.27 M(-80.2%) | $2.43 M(+3.0%) | $9.27 M(-79.2%) |
| Sept 2011 | - | $2.36 M(+21.1%) | $44.55 M(-0.1%) |
| June 2011 | - | $1.95 M(-22.4%) | $44.60 M(-2.2%) |
| Mar 2011 | - | $2.52 M(-93.3%) | $45.60 M(-2.6%) |
| Dec 2010 | $46.79 M(+208.3%) | $37.72 M(+1466.5%) | $46.79 M(+239.0%) |
| Sept 2010 | - | $2.41 M(-18.4%) | $13.80 M(-10.5%) |
| June 2010 | - | $2.95 M(-20.5%) | $15.43 M(+1.8%) |
| Mar 2010 | - | $3.71 M(-21.6%) | $15.16 M(-0.1%) |
| Dec 2009 | $15.18 M(+103.6%) | $4.73 M(+17.4%) | $15.18 M(+13.0%) |
| Sept 2009 | - | $4.03 M(+50.1%) | $13.44 M(+14.2%) |
| June 2009 | - | $2.69 M(-28.1%) | $11.76 M(+6.6%) |
| Mar 2009 | - | $3.73 M(+24.9%) | $11.04 M(+48.1%) |
| Dec 2008 | $7.46 M(+430.4%) | $2.99 M(+26.8%) | $7.46 M(+53.7%) |
| Sept 2008 | - | $2.36 M(+20.2%) | $4.85 M(+75.7%) |
| June 2008 | - | $1.96 M(+1230.8%) | $2.76 M(+96.0%) |
| Mar 2008 | - | $147.40 K(-61.6%) | $1.41 M(+0.2%) |
| Dec 2007 | $1.41 M(+56.3%) | $383.40 K(+42.5%) | $1.41 M(-153.5%) |
| Sept 2007 | - | $269.00 K(-55.8%) | -$2.63 M(+2.7%) |
| June 2007 | - | $609.20 K(+323.1%) | -$2.56 M(-3.9%) |
| Mar 2007 | - | $144.00 K(-103.9%) | -$2.66 M(-396.2%) |
| Dec 2006 | $899.20 K(-70.9%) | -$3.65 M(-1177.2%) | $899.20 K(-82.7%) |
| Sept 2006 | - | $339.00 K(-32.9%) | $5.19 M(-8.9%) |
| June 2006 | - | $505.50 K(-86.4%) | $5.69 M(-2.3%) |
| Mar 2006 | - | $3.71 M(+484.3%) | $5.82 M(+88.6%) |
| Dec 2005 | $3.09 M(-55.0%) | $634.30 K(-25.1%) | $3.09 M(-38.1%) |
| Sept 2005 | - | $846.30 K(+32.8%) | $4.99 M(+6.8%) |
| June 2005 | - | $637.20 K(-34.3%) | $4.67 M(-5.2%) |
| Mar 2005 | - | $970.60 K(-61.7%) | $4.93 M(-29.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2004 | $6.86 M(+48.0%) | $2.54 M(+380.9%) | $6.99 M(+31.6%) |
| Sept 2004 | - | $527.50 K(-40.9%) | $5.31 M(-21.9%) |
| June 2004 | - | $893.00 K(-70.5%) | $6.80 M(-2.7%) |
| Mar 2004 | - | $3.03 M(+253.4%) | $6.98 M(+50.7%) |
| Dec 2003 | $4.63 M(-30.9%) | $857.70 K(-57.4%) | $4.63 M(+1.0%) |
| Sept 2003 | - | $2.02 M(+86.9%) | $4.59 M(-35.7%) |
| June 2003 | - | $1.08 M(+58.2%) | $7.13 M(+6.5%) |
| Mar 2003 | - | $681.70 K(-15.9%) | $6.70 M(-0.1%) |
| Dec 2002 | $6.70 M(+100.4%) | $810.80 K(-82.2%) | $6.70 M(-1.8%) |
| Sept 2002 | - | $4.56 M(+609.5%) | $6.83 M(+128.0%) |
| June 2002 | - | $642.80 K(-7.0%) | $2.99 M(-5.8%) |
| Mar 2002 | - | $690.90 K(-26.2%) | $3.18 M(-5.0%) |
| Dec 2001 | $3.35 M(+338.4%) | $935.70 K(+29.0%) | $3.35 M(+23.4%) |
| Sept 2001 | - | $725.50 K(-12.1%) | $2.71 M(+26.7%) |
| June 2001 | - | $825.80 K(-3.9%) | $2.14 M(+45.8%) |
| Mar 2001 | - | $859.00 K(+184.8%) | $1.47 M(+92.4%) |
| Dec 2000 | $763.20 K(-48.6%) | $301.60 K(+96.0%) | $763.20 K(+71.5%) |
| Sept 2000 | - | $153.90 K(0.0%) | $445.10 K(-24.7%) |
| June 2000 | - | $153.90 K(+0.1%) | $591.20 K(-54.0%) |
| Mar 2000 | - | $153.80 K(-1032.1%) | $1.29 M(-10.2%) |
| Dec 1999 | $1.48 M(-31.0%) | -$16.50 K(-105.5%) | $1.43 M(-42.7%) |
| Sept 1999 | - | $300.00 K(-64.6%) | $2.50 M(-3.8%) |
| June 1999 | - | $847.90 K(+182.6%) | $2.60 M(+26.7%) |
| Mar 1999 | - | $300.00 K(-71.4%) | $2.05 M(-4.7%) |
| Dec 1998 | $2.15 M(+80.4%) | $1.05 M(+162.6%) | $2.15 M(+44.1%) |
| Sept 1998 | - | $400.00 K(+33.3%) | $1.49 M(+25.2%) |
| June 1998 | - | $300.00 K(-25.0%) | $1.19 M(-25.1%) |
| Mar 1998 | - | $400.00 K(+2.0%) | $1.59 M(+23.2%) |
| Dec 1997 | $1.19 M(+8.4%) | $392.10 K(+292.1%) | $1.29 M(+7.7%) |
| Sept 1997 | - | $100.00 K(-85.7%) | $1.20 M(0.0%) |
| June 1997 | - | $700.00 K(+600.0%) | $1.20 M(+71.4%) |
| Mar 1997 | - | $100.00 K(-66.7%) | $700.00 K(-41.7%) |
| Dec 1996 | $1.10 M(-72.5%) | $300.00 K(+200.0%) | $1.20 M(-33.3%) |
| Sept 1996 | - | $100.00 K(-50.0%) | $1.80 M(-28.0%) |
| June 1996 | - | $200.00 K(-66.7%) | $2.50 M(-28.6%) |
| Mar 1996 | - | $600.00 K(-33.3%) | $3.50 M(-14.6%) |
| Dec 1995 | $4.00 M(-42.9%) | $900.00 K(+12.5%) | $4.10 M(-2.4%) |
| Sept 1995 | - | $800.00 K(-33.3%) | $4.20 M(-14.3%) |
| June 1995 | - | $1.20 M(0.0%) | $4.90 M(-16.9%) |
| Mar 1995 | - | $1.20 M(+20.0%) | $5.90 M(-15.7%) |
| Dec 1994 | $7.00 M(-22.2%) | $1.00 M(-33.3%) | $7.00 M(-14.6%) |
| Sept 1994 | - | $1.50 M(-31.8%) | $8.20 M(-6.8%) |
| June 1994 | - | $2.20 M(-4.3%) | $8.80 M(-4.3%) |
| Mar 1994 | - | $2.30 M(+4.5%) | $9.20 M(+1.1%) |
| Dec 1993 | $9.00 M(+36.4%) | $2.20 M(+4.8%) | $9.10 M(+31.9%) |
| Sept 1993 | - | $2.10 M(-19.2%) | $6.90 M(-10.4%) |
| June 1993 | - | $2.60 M(+18.2%) | $7.70 M(+2.7%) |
| Mar 1993 | - | $2.20 M(-24.1%) | $7.50 M(-30.6%) |
| Dec 1992 | $6.60 M(-25.8%) | - | - |
| Oct 1992 | - | $2.90 M(+20.8%) | $10.80 M(+12.5%) |
| July 1992 | - | $2.40 M(0.0%) | $9.60 M(+7.9%) |
| Apr 1992 | - | $2.40 M(-22.6%) | $8.90 M(-1.1%) |
| Apr 1992 | $8.90 M(-12.7%) | - | - |
| Jan 1992 | - | $3.10 M(+82.4%) | $9.00 M(+5.9%) |
| Oct 1991 | - | $1.70 M(0.0%) | $8.50 M(-9.6%) |
| July 1991 | - | $1.70 M(-32.0%) | $9.40 M(-7.8%) |
| Apr 1991 | $10.20 M(-6.4%) | $2.50 M(-3.8%) | $10.20 M(-8.1%) |
| Jan 1991 | - | $2.60 M(0.0%) | $11.10 M(-7.5%) |
| Oct 1990 | - | $2.60 M(+4.0%) | $12.00 M(+1.7%) |
| July 1990 | - | $2.50 M(-26.5%) | $11.80 M(+3.5%) |
| Apr 1990 | $10.90 M(+39.7%) | $3.40 M(-2.9%) | $11.40 M(+10.7%) |
| Jan 1990 | - | $3.50 M(+45.8%) | $10.30 M(+18.4%) |
| Oct 1989 | - | $2.40 M(+14.3%) | $8.70 M(+6.1%) |
| July 1989 | - | $2.10 M(-8.7%) | $8.20 M(+5.1%) |
| Apr 1989 | $7.80 M(+69.6%) | $2.30 M(+21.1%) | $7.80 M(+23.8%) |
| Jan 1989 | - | $1.90 M(0.0%) | $6.30 M(+6.8%) |
| Oct 1988 | - | $1.90 M(+11.8%) | $5.90 M(+13.5%) |
| July 1988 | - | $1.70 M(+112.5%) | $5.20 M(+15.6%) |
| Apr 1988 | $4.60 M(+109.1%) | $800.00 K(-46.7%) | $4.50 M(+15.4%) |
| Jan 1988 | - | $1.50 M(+25.0%) | $3.90 M(+21.9%) |
| Oct 1987 | - | $1.20 M(+20.0%) | $3.20 M(+23.1%) |
| July 1987 | - | $1.00 M(+400.0%) | $2.60 M(+44.4%) |
| Apr 1987 | $2.20 M(+2100.0%) | $200.00 K(-75.0%) | $1.80 M(+12.5%) |
| Jan 1987 | - | $800.00 K(+33.3%) | $1.60 M(+77.8%) |
| Oct 1986 | - | $600.00 K(+200.0%) | $900.00 K(+125.0%) |
| July 1986 | - | $200.00 K(+100.0%) | $400.00 K(+33.3%) |
| Apr 1986 | $100.00 K | - | - |
| Jan 1986 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| Oct 1985 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| July 1985 | - | $100.00 K | $100.00 K |
FAQ
- What is Celldex Therapeutics annual revenue?
- What is the all time high annual revenue for Celldex Therapeutics?
- What is Celldex Therapeutics annual revenue year-on-year change?
- What is Celldex Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly revenue year-on-year change?
- What is Celldex Therapeutics TTM revenue?
- What is the all time high TTM revenue for Celldex Therapeutics?
- What is Celldex Therapeutics TTM revenue year-on-year change?
What is Celldex Therapeutics annual revenue?
The current annual revenue of CLDX is $6.88 M
What is the all time high annual revenue for Celldex Therapeutics?
Celldex Therapeutics all-time high annual revenue is $46.79 M
What is Celldex Therapeutics annual revenue year-on-year change?
Over the past year, CLDX annual revenue has changed by +$4.53 M (+192.02%)
What is Celldex Therapeutics quarterly revenue?
The current quarterly revenue of CLDX is $3.19 M
What is the all time high quarterly revenue for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly revenue is $37.72 M
What is Celldex Therapeutics quarterly revenue year-on-year change?
Over the past year, CLDX quarterly revenue has changed by +$1.67 M (+110.35%)
What is Celldex Therapeutics TTM revenue?
The current TTM revenue of CLDX is $9.98 M
What is the all time high TTM revenue for Celldex Therapeutics?
Celldex Therapeutics all-time high TTM revenue is $46.79 M
What is Celldex Therapeutics TTM revenue year-on-year change?
Over the past year, CLDX TTM revenue has changed by +$5.61 M (+128.55%)